Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 6/20 | 0.56 |
| ▸ | CA1 | P00915 | 4/20 | 0.56 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.52 |
| ▸ | MEN1 | O00255 | 1/20 | 0.52 |
| ▸ | FAAH | O00519 | 1/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.52 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.49 |
| ▸ | MMP2 | P08253 | 6/20 | 0.47 |
| ▸ | MMP3 | P08254 | 6/20 | 0.47 |
| ▸ | MMP1 | P03956 | 4/20 | 0.47 |
| ▸ | BIRC2 | Q13490 | 2/20 | 0.47 |
| ▸ | MMP7 | P09237 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11095965 | 0.92 | CA2 (0.66) | CA2CA1MAPK1MEN1FAAH | |
| SCHEMBL18612401 | 0.92 | MEN1 (0.55) | CA2CA1MAPK1MEN1FAAH | |
| SCHEMBL20746954 | 0.92 | MEN1 (0.55) | CA2CA1MAPK1MEN1FAAH | |
| SCHEMBL5528767 | 0.89 | MEN1 (0.52) | CA2CA1MAPK1MEN1FAAH | |
| SCHEMBL7981241 | 0.84 | CA2 (0.51) | CA2CA1MAPK1MMP2MMP3 | |
| SCHEMBL5901979 | 0.84 | FAAH (0.55) | CA2CA1MAPK1FAAHMMP2 | |
| SCHEMBL26992372 | 0.84 | HDAC8 (0.50) | CA2CA1MAPK1MEN1FAAH | |
| SCHEMBL29063421 | 0.82 | BIRC2 (0.70) | CA2CA1MMP2MMP3MMP1 | |
| SCHEMBL20936460 | 0.81 | CA2 (0.85) | CA2CA1MAPK1MMP2MMP3 | |
| SCHEMBL20915578 | 0.81 | CA2 (0.85) | CA2CA1MAPK1MMP2MMP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2430023-A1 | AZACYCLIC SPIRODERIVATIVES AS HSL INHIBITORS | F. Hoffmann-La Roche AG (CH) | 2012-03-21 | — | — | EP | disclosed |
| WO-2010130665-A1 | AZACYCLIC SPIRODERIVATIVES AS HSL INHIBITORS | F. HOFFMANN-LA ROCHE AG (CH) | 2010-11-18 | — | — | WO | disclosed |